SCHEMBL4392529

SCHEMBL4392529

[CH2]CNc1nc(NCc2ccc(Cl)c(Cl)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.48
SIRT5 Q9NXA8 1/20 0.42
PRKCQ Q04759 3/20 0.40
CLK4 Q9HAZ1 4/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
DYRK1A Q13627 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
JAK2 O60674 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HKDC1 Q2TB90 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4379701 0.90 MAPT (0.46) MAPTSIRT5PRKCQCLK4NPC1
SCHEMBL4380349 0.86 MAPT (0.55) MAPTSIRT5PRKCQNPC1RAB9A
SCHEMBL4383230 0.84 SIRT5 (0.59) MAPTSIRT5ALDH1A1
SCHEMBL1182313 0.84 SIRT5 (0.59) MAPTSIRT5ALDH1A1
SCHEMBL1181753 0.83 SIRT5 (0.48) MAPTSIRT5PRKCQIDO1TDO2
SCHEMBL1182432 0.82 SIRT5 (0.59) MAPTSIRT5TDP1
SCHEMBL906408 0.82 MAPT (0.49) MAPTSIRT5RAB9A
SCHEMBL4384924 0.81 MAPT (0.54) MAPTSIRT5PRKCQSMN1; SMN2IDO1
SCHEMBL3171667 0.80 MAPT (0.48) MAPTSIRT5PRKCQCLK4RAB9A
SCHEMBL1182065 0.79 MAPT (0.49) MAPTSIRT5CLK4ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066665-A2 BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROYL COA DESATURASE INHIBITORS CV THERAPEUTICS, INC. (US) 2009-06-10 EP disclosed
WO-2008043087-A2 BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROYL COA DESATURASE INHIBITORS CV THERAPEUTICS, INC. (US) 2008-04-10 WO disclosed